Bionomics Limited Probability of Future Pink Sheet Price Finishing Over 0.01

BNOEFDelisted Stock  USD 0.01  0.00  0.00%   
Bionomics' future price is the expected price of Bionomics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Bionomics Limited performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
  
Please specify Bionomics' target price for which you would like Bionomics odds to be computed.

Bionomics Target Price Odds to finish over 0.01

The tendency of Bionomics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.01  in 90 days
 0.01 90 days 0.01 
under 95
Based on a normal probability distribution, the odds of Bionomics to stay above $ 0.01  in 90 days from now is under 95 (This Bionomics Limited probability density function shows the probability of Bionomics Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Bionomics Limited price to stay between $ 0.01  and its current price of $0.0131 at the end of the 90-day period is about 8.3 .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 6.44 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bionomics will likely underperform. In addition to that Bionomics Limited has an alpha of 3.4659, implying that it can generate a 3.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bionomics Price Density   
       Price  

Predictive Modules for Bionomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionomics Limited. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bionomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.020.020.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.020.02
Details

Bionomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bionomics is not an exception. The market had few large corrections towards the Bionomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bionomics Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bionomics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.47
β
Beta against Dow Jones6.44
σ
Overall volatility
0.01
Ir
Information ratio 0.12

Bionomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bionomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bionomics Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bionomics Limited is not yet fully synchronised with the market data
Bionomics Limited has some characteristics of a very speculative penny stock
Bionomics Limited has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 263.63 K. Net Loss for the year was (21.76 M) with loss before overhead, payroll, taxes, and interest of (9.94 M).
Bionomics Limited has accumulated about 33.56 M in cash with (21.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Bionomics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bionomics Pink Sheet often depends not only on the future outlook of the current and potential Bionomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bionomics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.4 B

Bionomics Technical Analysis

Bionomics' future price can be derived by breaking down and analyzing its technical indicators over time. Bionomics Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bionomics Limited. In general, you should focus on analyzing Bionomics Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Bionomics Predictive Forecast Models

Bionomics' time-series forecasting models is one of many Bionomics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bionomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Bionomics Limited

Checking the ongoing alerts about Bionomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bionomics Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bionomics Limited is not yet fully synchronised with the market data
Bionomics Limited has some characteristics of a very speculative penny stock
Bionomics Limited has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 263.63 K. Net Loss for the year was (21.76 M) with loss before overhead, payroll, taxes, and interest of (9.94 M).
Bionomics Limited has accumulated about 33.56 M in cash with (21.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Bionomics Pink Sheet

If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity